A pilot study of health and wellness coaching for fibromyalgia

Hackshaw, Kevin V.; Plans, Marçal; Rodríguez-Saona, Luis E.; Moore, Margaret; Jackson, Erika K.; Sforzo, Gary A.; Buffington, C.A. Tony

doi:10.1186/s12891-016-1316-0

Cited by 17 publications

(13 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Alternatively, we surmise that many patients feel that the "diagnosis" is still subjective, and satisfaction may never be achieved for the great majority until we have a widely accepted gold standard or biomarker. Unfortunately, current Food and Drug Administration-approved therapies for FM have not been able to show superior efficacy over mindfulness techniques or health coaching (45,46).…”

Section: Tablementioning

confidence: 99%

Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders

Hackshaw

Aykas

Sigurdson

et al. 2019

Journal of Biological Chemistry

Self Cite

View full text Add to dashboard Cite

Diagnosis and treatment of fibromyalgia (FM) remains a challenge owing to the lack of reliable biomarkers. Our objective was to develop a rapid biomarker-based method for diagnosing FM by using vibrational spectroscopy to differentiate patients with FM from those with rheumatoid arthritis (RA), osteoarthritis (OA), or systemic lupus erythematosus (SLE) and to identify metabolites associated with these differences. Blood samples were collected from patients with a diagnosis of FM (n ‫؍‬ 50), RA (n ‫؍‬ 29), OA (n ‫؍‬ 19), or SLE (n ‫؍‬ 23). Bloodspot samples were prepared, and spectra collected with portable FT-IR and FT-Raman microspectroscopy and subjected to metabolomics analysis by ultra-HPLC (uHPLC), coupled to a photodiode array (PDA) and tandem MS/MS. Unique IR and Raman spectral signatures were identified by pattern recognition analysis and clustered all study participants into classes (FM, RA, and SLE) with no misclassifications (p < 0.05, and interclass distances > 2.5). Furthermore, the spectra correlated (r ‫؍‬ 0.95 and 0.83 for IR and Raman, respectively) with FM pain severity measured with fibromyalgia impact questionnaire revised version (FIQR) assessments. Protein backbones and pyridine-carboxylic acids dominated this discrimination and might serve as biomarkers for syndromes such as FM. uHPLC-PDA-MS/MS provided insights into metabolites significantly differing among the disease groups, not only in molecular m/z ؉ and m/z ؊ values but also in UV-visible chromatograms. We conclude that vibrational spectroscopy may provide a reliable diagnostic test for differentiating FM from other disorders and for establishing serologic biomarkers of FM-associated pain.

show abstract

Section: Tablementioning

confidence: 99%

Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders

Hackshaw

Aykas

Sigurdson

et al. 2019

Journal of Biological Chemistry

Self Cite

View full text Add to dashboard Cite

show abstract

“…These activities will be supported by health professionals initially, although support will be gradually reduced to promote patient autonomy. In this way, we hope that patients will take leadership of their physical activity [14].…”

Section: Background and Rationale {6a}mentioning

confidence: 97%

“…This is called life-style coaching. A cohort pilot study of 10 individuals with fibromyalgia [14] showed a 37% improvement in quality of life measured with the Revised Fibromyalgia Impact Questionnaire following life-style coaching sessions with health professionals.…”

Section: Background and Rationale {6a}mentioning

confidence: 99%

“…As part of an effort to improve the management of patients with fibromyalgia, we have decided to continue the work of Hackshaw et al [14] and use a pragmatic approach to exercise as part of the management of fibromyalgia. We wish to evaluate patient-led physical activity that is orientated towards the management of fibromyalgia.…”

Section: Background and Rationale {6a}mentioning

confidence: 99%

See 1 more Smart Citation

Comparison of patient-led, fibromyalgia-orientated physical activity and a non-specific, standardised 6-month physical activity program on quality of life in individuals with fibromyalgia: a protocol for a randomised controlled trial

Rulleau

Planche

Etcheverrigaray³

et al. 2020

Trials

View full text Add to dashboard Cite

Background Exercise has been shown to significantly improve pain and function in individuals with fibromyalgia. Research into the effectiveness of exercise is often based on standardised exercise programmes that are chosen by the investigating clinical research team. However, such programmes may not necessarily be appealing to the participating patients. Furthermore, in addition to being taught exercises, patients with chronic conditions like fibromyalgia also need to learn to manage their condition themselves and so be actively involved in their treatment. The primary aim of this study is to compare the effects of two, 6-month physical activity programs on quality of life in patients with fibromyalgia. One group followed a patient-led, fibromyalgia-orientated programme (experimental) whilst the control group followed a standard, general exercise programme. Methods This protocol is an open-label, two-centre, randomised, controlled superiority trial. Two treatment arms will be compared: an experimental group (patient-led, fibromyalgia-orientated exercise) and a control group (general exercise program). The control group will participate in the exercise programme currently provided in our centre, which involves general, group exercise for patients with various pathologies. The experimental group will be taught the principles of exercise specifically for fibromyalgia during a one-to-one coaching session. They will then be guided in the choice of one or several types of exercise that they enjoy. They will be instructed to perform the exercise according to the recommendations for exercise in fibromyalgia with regard to intensity, duration and frequency. The protocol will last for 6 months; participants will then be followed-up for a further 6 months. They will also be encouraged to continue exercising after the end of the protocol. Outcomes will be evaluated at baseline, 6 and 12 months. The primary outcome will be quality of life (Fibromyalgia Impact Questionnaire) and the secondary outcomes will include measures of pain (including a visual analogue scale and the neuropathic characteristics of the pain), depression (Hospital Anxiety and Depression Scale), kinesiophobia (Tampa scale of kinesiophobia) and adherence (Polar OH1 heart rate monitor). Discussion The results of this study will show if patient-led, fibromyalgia-orientated exercise is more effective than a general exercise programme on fibromyalgia-related outcomes, including quality of life, and on adherence to continued exercise. Trial registration ClinicalTrials.gov NCT03895086. Registration no. 2018-A02881-54. Registered on 29 March 2019

show abstract

“…1,2,5,10 En cuanto a la educación, es importante que el paciente conozca acerca de su enfermedad, factores protectores o agravantes, sintomatología, opciones de tratamiento y pronóstico, Gómez Arias EM, Rengifo Varona ML Rev Col Med Fis Rehab 2017;27 (2):123-139 -http://revistacmfr.org DOI: http://dx.doi.org/10.28957/rcmfr.v27n2a1 partiendo de que la FM es una enfermedad cró-nica para la cual aún no existe cura. 1,10,44,45 La terapia física ofrece diferentes intervenciones que mejoran el dolor y algunos aspectos de la condición física. Para el manejo del dolor se encuentran diferentes alternativas según el caso: masajes, medios físicos, ultrasonido y electro-estimulación.…”

Section: Tratamiento No Farmacológicounclassified

Visión desde la rehabilitación del paciente con fibromialgia

Árias

Varona

2017

Rev Col Med Fis Reh

View full text Add to dashboard Cite

RESUMENLa fibromialgia (FM) es una de las causas más frecuentes de dolor crónico musculoesquelético difuso, no inflamatorio, no oncológico. Por lo general se encuentra asociada a trastornos afectivos como depresión y ansiedad, alteraciones del sueño, deterioro cognitivo y múltiples síntomas somáticos inespecíficos, que afectan la funcionalidad y la participación de los individuos en la esfera biopsicosocial, así como la calidad de vida. Por este motivo, es importante realizar, desde la visión de la rehabilitación, un abordaje integral del paciente con FM desde su diagnóstico, hasta su tratamiento, rehabilitación y seguimiento; brindar estrategias con las cuales se pueda disminuir y controlar al máximo la sintomatología, con el fin de mejorar la calidad de vida, la funcionalidad y la independencia de los pacientes. Palabras clave: fibromialgia, dolor crónico, rehabilitación, calidad de vida. DOI: 10.28957/rcmfr.v27n2a1 ABSTRACT Fibromyalgia (FM) is one of the most frequent causes of diffuse, non-inflammatory, nononcologic chronic musculoskeletal pain. It is usually associated with affective disorders such as depression, anxiety, sleep disturbances, cognitive impairment, and multiple nonspecific somatic symptoms that affect the functionality and participation of individuals in the biopsychosocial sphere, as well as quality of life. For this reason, it is important from the vision of rehabilitation to perform an integral approach of the patient with FM from its diagnosis, to its treatment, rehabilitation and follow-up; Provide strategies to reduce and control symptomatology to the maximum, in order to improve the quality of life, functionality and independence of patients.

show abstract

A pilot study of health and wellness coaching for fibromyalgia

Cited by 17 publications

References 39 publications

Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders

Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders

Comparison of patient-led, fibromyalgia-orientated physical activity and a non-specific, standardised 6-month physical activity program on quality of life in individuals with fibromyalgia: a protocol for a randomised controlled trial

Visión desde la rehabilitación del paciente con fibromialgia

Contact Info

Product

Resources

About